Literature DB >> 16365299

Deregulation of common genes by c-Myc and its direct target, MT-MC1.

Kenneth R Rogulski1, Debra E Cohen, David L Corcoran, Panayiotis V Benos, Edward V Prochownik.   

Abstract

In addition to its role in cancer, the c-Myc oncoprotein controls many normal cellular processes as a consequence of its function as a basic helix-loop-helix leucine zipper transcription factor. Determining which of the myriad genes under c-Myc control are relevant for these various roles is thus a major challenge. mt-mc1 is a direct c-Myc target gene whose overexpression recapitulates multiple c-Myc phenotypes, including transformation. Using transcriptional profiling, we now show that MT-MC1-overexpressing myeloid cells misregulate a total of 47 distinct transcripts, a large proportion of which are involved in signal transduction and/or cancer. Analysis of these genes reveals a consensus promoter structure consisting of multiple, often closely spaced c-Myc binding sites and three additional Wilm's tumor and Egr1-like motifs. More than one-third of MT-MC1 target genes are also clustered on six cancer-associated chromosomal loci. Most surprisingly, all of the transcripts examined also are regulated by c-Myc. Finally, an estrogen receptor-MT-MC1 fusion protein was used to establish that all examined transcripts were regulated directly by the chimeric protein. Our results thus indicate that MT-MC1 target genes largely comprise a subset of those regulated by c-Myc. We propose that the properties imparted by MT-MC1 are the result of its control of a small and select c-Myc target gene population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16365299      PMCID: PMC1323176          DOI: 10.1073/pnas.0507902102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Identifying DNA and protein patterns with statistically significant alignments of multiple sequences.

Authors:  G Z Hertz; G D Stormo
Journal:  Bioinformatics       Date:  1999 Jul-Aug       Impact factor: 6.937

2.  A computational analysis of whole-genome expression data reveals chromosomal domains of gene expression.

Authors:  B A Cohen; R D Mitra; J D Hughes; G M Church
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

3.  Myc target in myeloid cells-1, a novel c-Myc target, recapitulates multiple c-Myc phenotypes.

Authors:  Xiaoying Yin; Linnette Grove; Kenneth Rogulski; Edward V Prochownik
Journal:  J Biol Chem       Date:  2002-03-21       Impact factor: 5.157

4.  Identification of CDK4 as a target of c-MYC.

Authors:  H Hermeking; C Rago; M Schuhmacher; Q Li; J F Barrett; A J Obaya; B C O'Connell; M K Mateyak; W Tam; F Kohlhuber; C V Dang; J M Sedivy; D Eick; B Vogelstein; K W Kinzler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

Review 5.  The myc oncogene: MarvelouslY Complex.

Authors:  Sara K Oster; Cynthia S W Ho; Erinn L Soucie; Linda Z Penn
Journal:  Adv Cancer Res       Date:  2002       Impact factor: 6.242

6.  Inverse regulation of cyclin B1 by c-Myc and p53 and induction of tetraploidy by cyclin B1 overexpression.

Authors:  X Y Yin; L Grove; N S Datta; K Katula; M W Long; E V Prochownik
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

7.  HMG-I/Y, a new c-Myc target gene and potential oncogene.

Authors:  L J Wood; M Mukherjee; C E Dolde; Y Xu; J F Maher; T E Bunton; J B Williams; L M Resar
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

8.  The human transcriptome map: clustering of highly expressed genes in chromosomal domains.

Authors:  H Caron; B van Schaik ; M van der Mee ; F Baas; G Riggins; P van Sluis ; M C Hermus; R van Asperen ; K Boon; P A Voûte; S Heisterkamp; A van Kampen ; R Versteeg
Journal:  Science       Date:  2001-02-16       Impact factor: 47.728

9.  Genetic dissection of c-myc apoptotic pathways.

Authors:  C E Nesbit; J M Tersak; L E Grove; A Drzal; H Choi; E V Prochownik
Journal:  Oncogene       Date:  2000-06-29       Impact factor: 9.867

10.  Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection.

Authors:  C Li; W H Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

View more
  14 in total

1.  Proteotranscriptomic Profiling of 231-BR Breast Cancer Cells: Identification of Potential Biomarkers and Therapeutic Targets for Brain Metastasis.

Authors:  Matthew D Dun; Robert J Chalkley; Sam Faulkner; Sheridan Keene; Kelly A Avery-Kiejda; Rodney J Scott; Lasse G Falkenby; Murray J Cairns; Martin R Larsen; Ralph A Bradshaw; Hubert Hondermarck
Journal:  Mol Cell Proteomics       Date:  2015-06-03       Impact factor: 5.911

2.  Tamoxifen induces a pluripotency signature in breast cancer cells and human tumors.

Authors:  George Notas; Vassiliki Pelekanou; Marilena Kampa; Konstantinos Alexakis; Stelios Sfakianakis; Aggelos Laliotis; John Askoxilakis; Eleftheria Tsentelierou; Maria Tzardi; Andreas Tsapis; Elias Castanas
Journal:  Mol Oncol       Date:  2015-06-05       Impact factor: 6.603

3.  Widespread genomic instability mediated by a pathway involving glycoprotein Ib alpha and Aurora B kinase.

Authors:  Youjun Li; Fengfeng L Xu; Jie Lu; William S Saunders; Edward V Prochownik
Journal:  J Biol Chem       Date:  2010-02-15       Impact factor: 5.157

4.  Th-MYCN mice with caspase-8 deficiency develop advanced neuroblastoma with bone marrow metastasis.

Authors:  Tal Teitz; Madoka Inoue; Marcus B Valentine; Kejin Zhu; Jerold E Rehg; Wei Zhao; David Finkelstein; Yong-Dong Wang; Melissa D Johnson; Christopher Calabrese; Marcelo Rubinstein; Razqallah Hakem; William A Weiss; Jill M Lahti
Journal:  Cancer Res       Date:  2013-03-27       Impact factor: 12.701

5.  Gene signatures in wound tissue as evidenced by molecular profiling in the chick embryo model.

Authors:  Fabienne Soulet; Witold W Kilarski; Philipp Antczak; John Herbert; Roy Bicknell; Francesco Falciani; Andreas Bikfalvi
Journal:  BMC Genomics       Date:  2010-09-14       Impact factor: 3.969

6.  c-Myc-mediated genomic instability proceeds via a megakaryocytic endomitosis pathway involving Gp1balpha.

Authors:  Youjun Li; Jie Lu; Edward V Prochownik
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

7.  Modularity of the oncoprotein-like properties of platelet glycoprotein Ibalpha.

Authors:  Youjun Li; Jie Lu; Edward V Prochownik
Journal:  J Biol Chem       Date:  2008-11-18       Impact factor: 5.157

8.  Myc and ChREBP transcription factors cooperatively regulate normal and neoplastic hepatocyte proliferation in mice.

Authors:  Huabo Wang; James M Dolezal; Sucheta Kulkarni; Jie Lu; Jordan Mandel; Laura E Jackson; Frances Alencastro; Andrew W Duncan; Edward V Prochownik
Journal:  J Biol Chem       Date:  2018-08-07       Impact factor: 5.157

9.  Promoter hypermethylation-induced transcriptional down-regulation of the gene MYCT1 in laryngeal squamous cell carcinoma.

Authors:  Min Yang; Wei Li; Yi-Ying Liu; Shuang Fu; Guang-Bin Qiu; Kai-Lai Sun; Wei-Neng Fu
Journal:  BMC Cancer       Date:  2012-06-06       Impact factor: 4.430

10.  Gene profiling of the erythro- and megakaryoblastic leukaemias induced by the Graffi murine retrovirus.

Authors:  Veronique Voisin; Philippe Legault; Diana Paulina Salazar Ospina; Yaacov Ben-David; Eric Rassart
Journal:  BMC Med Genomics       Date:  2010-01-26       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.